Jabra Enhance Select 200 vs Signia Pure C&G IX

The Jabra Enhance Select 200 is a premium-priced OTC hearing aid that earns a B grade with a SoundScore of 3.9/5 in our lab testing, ranking in the top 35% of OTC devices. At $1,695, it sits at the higher end of the OTC market and has earned HearAdvisor's Expert's Choice Award in both 2023 and 2024. This behind-the-ear device delivers its strongest performance in speech clarity during quiet environments, scoring 3.5/5—a solid result that sits 0.67 points above the OTC category average. Own-voice comfort is another highlight at 3.4/5, which is 0.89 points above average, meaning wearers are less likely to experience the bothersome "talking in a barrel" sensation. Music streaming scores 2.6/5, which is 0.68 points above the category average, though still mixed in absolute terms. The device shows some limitations in challenging listening situations. Speech in noise performance is low at 1.4/5, sitting slightly below the category average. Feedback handling scores a strong 4.0/5 in absolute terms, though this falls 0.54 points below the OTC average of 4.54/5. The Enhance Select 200 includes modern conveniences like rechargeable batteries and streaming compatibility with both iPhone and Android devices, plus hands-free calling capability. However, budget-conscious shoppers should note that several devices in this price range—including the Lucid Tala and Audicus Omni 2—achieve higher scores, and alternatives like the Lucid Engage offer similar sound quality at lower prices. This device is best suited for listeners who prioritize clear speech in quieter settings and natural own-voice quality over performance in noisy environments.

The Signia Pure C&G IX is a premium prescription behind-the-ear hearing aid released in 2023, currently available at $3,298. In HearAdvisor's lab testing, it earned an A grade with a SoundScore of 4.1/5, ranking #20 among 36 prescription hearing aids tested. This device demonstrates consistent strength across multiple performance areas. Speech in quiet scored a solid 4.0/5, sitting 0.65 points above the category average. Speech in noise performance, while above the category average by 0.25 points, remains mixed in absolute terms at 2.2/5—a common challenge across prescription devices. Feedback handling is a standout feature, achieving a perfect 5.0/5 and exceeding the already-high category average. Own-voice comfort scores a solid 3.2/5, running 0.45 points above the category average, which suggests good occlusion management. Music streaming performs solidly at 3.0/5, also above average for the category by 0.36 points. The device supports both iPhone and Android streaming along with hands-free functionality. Professional tuning yields meaningful improvement, with the normalized score increasing from 4.0/5 to 4.5/5. Buyers seeking top-tier performance in this price range should note that competitors like the Phonak Sphere Infinio (5.0/5) and Oticon Intent (4.85/5) scored higher in our testing. The Pure C&G IX may suit those who prioritize reliable feedback control and balanced everyday performance over maximum speech-in-noise capability.